A nonsignificant trend towards a survival benefit with epoetin has also been suggested by the results of a randomised, double-blind, placebo-controlled trial of 375 patients with solid or non-myeloid haematological malignancies receiving non-platinum-based chemotherapy ( Littlewood et al , 2001 ).
← all excerpts
Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: A meta-analysis.
1
—
—